These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23729081)

  • 1. Changes and alternatives for dialysis facilities under the bundled payment plan.
    Solid CA; Collins AJ
    Nephrol News Issues; 2013 May; 27(6):30-2. PubMed ID: 23729081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
    Bhat P; Sokolowski W; Bhat JG
    Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The initial impact of Medicare's new prospective payment system for kidney dialysis.
    Hirth RA; Turenne MN; Wheeler JR; Nahra TA; Sleeman KK; Zhang W; Messana JA
    Am J Kidney Dis; 2013 Oct; 62(4):662-9. PubMed ID: 23769138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using knowledge of multiple levels of variation in care to target performance incentives to providers.
    Turenne MN; Hirth RA; Pan Q; Wolfe RA; Messana JM; Wheeler JR
    Med Care; 2008 Feb; 46(2):120-6. PubMed ID: 18219239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs.
    Charytan C
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2355-62. PubMed ID: 21071515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
    Hornberger J; Hirth RA
    Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can we learn from the U.S. expanded end-stage renal disease bundle?
    Chambers JD; Weiner DE; Bliss SK; Neumann PJ
    Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the bundled end-stage renal disease payment system on patient care.
    Maddux FW
    Blood Purif; 2012; 33(1-3):107-11. PubMed ID: 22269932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis composite rate bundling: potential effects on the utilization of home hemodialysis, daily and nocturnal hemodialysis, and peritoneal dialysis.
    Blagg CR
    Semin Dial; 2011; 24(6):674-7. PubMed ID: 22107483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebasing the Medicare payment for dialysis: rationale, challenges, and opportunities.
    Wish D; Johnson D; Wish J
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2195-202. PubMed ID: 25189926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cut to bundled payment will still hurt.
    Neumann ME
    Nephrol News Issues; 2014 Jan; 28(1):8. PubMed ID: 24600922
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcimimetics and Bundled Reimbursement.
    Lin E; Watnick S
    Am J Kidney Dis; 2019 Mar; 73(3):385-390. PubMed ID: 30611600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic considerations in a changing anemia environment.
    Pizzi LT
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S29-33. PubMed ID: 19010259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
    Iglehart JK
    N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease care.
    Winkelmayer WC
    Blood Purif; 2011; 31(1-3):66-9. PubMed ID: 21228569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When payment systems collide: the effect of hospitalization on anemia in renal dialysis patients.
    Turenne MN; Hirth RA; Messana JM; Turner JS; Sleeman KK; Wheeler JR
    Med Care; 2010 Apr; 48(4):296-305. PubMed ID: 20195175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new Medicare PPS and home dialysis.
    Curtis J; Schatell D
    Nephrol News Issues; 2010 Sep; 24(10):30, 32-3. PubMed ID: 20942328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do resource utilization and clinical measures still vary across dialysis chains after controlling for the local practices of facilities and physicians?
    Hirth RA; Turenne MN; Wheeler JR; Ma Y; Messana JM
    Med Care; 2010 Aug; 48(8):726-32. PubMed ID: 20613666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.